|
Arribas-Leal JM, Rivera-Caravaca JM, Aranda-Domene R, Moreno-Moreno JA, Espinosa-Garcia D, Jimenez-Aceituna A, Perez-Andreu J, Taboada-Martin R, Saura-Espin DR, Canovas-Lopez SJ. Mid-term outcomes of rapid deployment aortic prostheses in patients with small aortic annulus. Interact Cardiovasc Thorac Surg. 2021 Oct 29;33(5):695-701. doi: 10.1093/icvts/ivab175. PubMed PMID: 34179967; PubMed Central PMCID: PMC8923414.
AÑO: 2021; IF: 1.978
|
34179967
|
Rivera-Caravaca JM, Badimon L, Ferreira-Gonzalez I, Gomez-Doblas JJ, Roca-Luque I, Lekuona I, Jimenez-Candil J, Rodriguez-Padial L, Gonzalez-Juanatey C, Calvo-Jambrina R, Facila L, Ruiz-Ortiz M, Anguita M, Marin F. Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry. Europace. 2022 Jan 4;24(1):4-11. doi: 10.1093/europace/euab131. PubMed PMID: 34115857.
AÑO: 2022; IF: 6.1
|
|
Ding WY, Rivera-Caravaca JM, Marin F, Li G, Roldan V, Lip GYH. Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence. Br J Clin Pharmacol. 2022 Jan;88(1):282-289. doi: 10.1111/bcp.14961. Epub 2021 Jul 13. PubMed PMID: 34192808.
AÑO: 2022; IF: 3.4
|
|
Rivera-Caravaca JM, Buckley BJR, Harrison SL, Fazio-Eynullayeva E, Underhill P, Marin F, Lip GYH. Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes. Thromb Res. 2021 Sep;205:1-7. doi: 10.1016/j.thromres.2021.06.014. Epub 2021 Jun 27. PubMed PMID: 34218058; PubMed Central PMCID: PMC8236305.
AÑO: 2021; IF: 10.407
|
|
Ding WY, Rivera-Caravaca JM, Marin F, Torp-Pedersen C, Roldan V, Lip GYH. Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS. J Clin Med. 2021 Jul 29;10(15):3357. doi: 10.3390/jcm10153357. PubMed PMID: 34362143; PubMed Central PMCID: PMC8348193.
AÑO: 2021; IF: 4.964
|